Article Document Academic Article Information Content Entity Continuant Continuant Journal Article Entity Entity Generically Dependent Continuant 2025-05-07T12:23:02 RDF description of Does clinical decision support increase appropriate medication prescribing for cardiovascular risk reduction? - http://repository.healthpartners.com/individual/document-rn34216 37444 Journal of the American Board of Family Medicine document-rn34216 public Risk Factors Primary Health Care Does clinical decision support increase appropriate medication prescribing for cardiovascular risk reduction? 36 <p>PURPOSE: To assess the impact of a clinical decision support (CDS) system's recommendations on prescribing patterns targeting cardiovascular disease (CVD) when the recommendations are prioritized in order from greatest to least benefit toward overall CVD risk reduction. METHODS: Secondary analysis of trial data from September 20, 2018, to March 15, 2020, where 70 community health center clinics were cluster-randomized to the CDS intervention (42 clinics; 8 organizations) or control group (28 clinics; 7 organizations). Included patients were medication-naïve and aged 40 to 75 years with � 1 uncontrolled cardiovascular disease risk factor, with known diabetes or cardiovascular disease, or � 10% 10-year reversible CVD risk. RESULTS: Among eligible encounters with 29,771 patients, the probability of prescribing a medication targeting hypertension was greater at intervention clinic encounters when CDS was used (34.9% [95% CI, 31.5 to 38.3]) versus dismissed (29.6% [95% CI, 26.7 to 32.6]; P�<�.001), but not when compared with control clinic encounters (34.9% [95% CI, 31.1 to 38.7]; P�=�.998). Prescribing for dyslipidemia was significantly higher at intervention encounters where the CDS system was used (11.3% [95% CI, 9.3 to 13.3]) compared with dismissed (7.7% [95% CI, 6.1 to 9.3]; P�=�.003) and to control encounters (8.7% [95% CI, 7.0 to 10.4]; P�=�.044); smoking cessation medication showed a similar pattern. Except for dyslipidemia, prescribing rates increased according to their prioritization. CONCLUSIONS: Use of this CDS system was associated with significantly higher prescribing targeting most cardiovascular risk factors. These results highlight how displaying prioritized actions to reduce reversible CVD risk could improve risk management. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03001713, https://clinicaltrials.gov/.<p> 21792 Cardiovascular Diseases Risk Reduction Drugs and Drug Therapy Decision Making 2023-10-13T21:04:25.261-05:00 10.3122/jabfm.2022.220391R2 Clinical Decision Support Systems Randomized Controlled Trials 5